Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q2 2024 Earnings

9MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-56.25

-37.74

-19.23

-0.73

Details

Expected EPS

-1.048908

Actual EPS

-1.2

Surprise EPS

-0.15

Surprise Percent

+14.4%

Description

Spyre Therapeutics (SYRE) has reported earnings of -1.2 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.